Cargando…
Bridging the gap: a review of dose investigations in paediatric investigation plans
AIMS: In the EU, development of new medicines for children should follow a prospectively agreed paediatric investigation plan (PIP). Finding the right dose for children is crucial but challenging due to the variability of pharmacokinetics across age groups and the limited sample sizes available. We...
Autores principales: | Hampson, Lisa V, Herold, Ralf, Posch, Martin, Saperia, Julia, Whitehead, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239983/ https://www.ncbi.nlm.nih.gov/pubmed/24720849 http://dx.doi.org/10.1111/bcp.12402 |
Ejemplares similares
-
Bridging the gap: a review of dose-investigation studies in paediatric investigation plans
por: Hampson, Lisa, et al.
Publicado: (2013) -
Innovative approaches to investigator-initiated, multicentre paediatric clinical trials in Canada
por: Kelly, Lauren E, et al.
Publicado: (2019) -
Bridging the Molecular-Cellular Gap in Understanding Ion Channel Clustering
por: Nirenberg, Valerie Abigail, et al.
Publicado: (2020) -
Oral Medicines for Children in the European Paediatric Investigation Plans
por: van Riet – Nales, Diana A., et al.
Publicado: (2014) -
Cardiovascular Paediatric Medicines Development: Have Paediatric Investigation Plans Lost Heart?
por: Faulkner, Bethany, et al.
Publicado: (2020)